Download PDF
Thromb Haemost 1997; 77(05): 0926-0933
DOI: 10.1055/s-0038-1656079
Coagulation
Schattauer GmbH Stuttgart

Properties of a Recombinant Chimeric Protein in which the gamma-Carboxyglutamic Acid and Helical Stack Domains of Human Anticoagulant Protein C Are Replaced by those of Human Coagulation Factor VII

Jie-Ping Geng
The Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA
,
Francis J Castellino
The Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA
› Author Affiliations
Further Information

Publication History

Received 15 November 1996

Accepted after revision 17 January 1997

Publication Date:
26 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

A chimeric cDNA, encoding residues 1-46 (the γ-carboxyglutamic acid module and its trailing helical stack) of human coagulant factor (f) VII, bound to residues 47-419 of human anticoagulant protein C (PC), was constructed and expressed. The resulting protein, r-[∆GD-HSPC/∇GD-HSfVII]PC, was properly processed with regard to signal/ propeptide release, cleavage of the K156R dipeptide, Gla and Hya contents, and the presence of glycosylation.

The mutant protein displayed normal dependencies on Ca2+ for adoption of its metal ion-dependent conformation and for binding to acidic phospholipid vesicles. The chimera failed to recognize a monoclonal antibody (MAb) specific for the Ca2+-induced conformation of the Gla domain (GD) of PC, but did react with another MAb directed in part to the Ca2+-dependent conformation of the GD of fVII. Further, this chimeric protein possessed similar steady state constants as wild-type r-PC toward activation by thrombin and thrombin/thrombomodulin. The activated form of the chimera was very similar to that of its wild- type counterpart in its whole plasma anticoagulant activity, as well as its activity toward inactivation of coagulation factor VIII. The chimeric protein did not bind to the fVII cofactor, tissue factor, showing that the GD/HS domain region of fVII is insufficient for that particular interaction.

The results demonstrate that the GD/HS of fVII, when present in the PC and APC background, serves to maintain the Ca2+/PL-related functions of these latter proteins, and suggest that the Ca2+ and PL- dependent interactions of the GD-HS of PC are sufficiently general in nature such that the GD-HS regions of other proteins of this type can satisfy most of the requirements of PC and APC. The data presented also offer support for the independent nature of the domain unit consisting of the GD/HS module.

 

  • References

  • 1 Walker FJ. Regulation of activated protein C by a new protein. J Biol Chem 1980; 255: 5521-5524
    PubMedSearch in Google Scholar
  • 2 Kisiel W, Canfield WM, Ericsson LH, Davie EW. Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry 1977; 16: 5824-5831
    CrossrefPubMedSearch in Google Scholar
  • 3 Vehar GA, Davie EW. Preparation and properties of bovine factor VIII (antihemophilic factor). Biochemistry 1980; 19: 401-410
    CrossrefPubMedSearch in Google Scholar
  • 4 Amphlett GW, Kisiel W, Castellino FJ. Interaction of calcium with bovine plasma protein C. Biochemistry 1981; 20: 2156-2161
    CrossrefPubMedSearch in Google Scholar
  • 5 Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1982; 257: 859-864
    PubMedSearch in Google Scholar
  • 6 Johnson AE, Esmon NL, Laue TM, Esmon CT. Structural changes required for activation of protein C are induced by Ca(II) binding to a high affinity site that does not contain γ-carboxyglutamic acid. J Biol Chem 1983; 258: 5554-5660
    PubMedSearch in Google Scholar
  • 7 Rezaie AR, Esmon CT. Tryptophans 231 and 234 in protein C report the Ca2+-dependent conformational change required for activation by the thrombin-thrombomodulin complex. Biochemistry 1995; 34: 12221-12226
    CrossrefPubMedSearch in Google Scholar
  • 8 Zushi M, Gomi K, Honda G, Kondo S, Yamamoto S, Hayashi T, Suzuki K. Aspartic acid 349 in the fourth epidermal growth factor-like structure of human thrombomodulin plays a role in its Ca2+-mediated binding to protein C. J Biol Chem 1991; 266: 19886-19989
    PubMedSearch in Google Scholar
  • 9 Clarke JH, Light DR, Blasko E, Parkinson JF, Nagashima M, McLean K, Vilander L, Andrews JH, Morser J, Glaser CB. The short loop between epidermal growth factor-like domains 4 and 5 is critical for human thrombomodulin function. J Biol Chem 1993; 268: 6309-6315
    PubMedSearch in Google Scholar
  • 10 Kisiel W, Ericsson LH, Davie EW. Proteolytic activation of protein C from bovine plasma. Biochemistry 1976; 15: 4893-4900
    CrossrefPubMedSearch in Google Scholar
  • 11 Beckmann RJ, Schmidt RJ, Santerre RF, Plutzky J, Crabtree GR, Long GL. The structure and evolution of a 461 amino acid human protein C precursor and its messenger RNA, based upon the DNA sequence of cloned human liver cDNAs. Nucleic Acids Res 1985; 13: 5233-5247
    CrossrefPubMedSearch in Google Scholar
  • 12 Zhang L, Castellino FJ. The contributions of individual gamma-carboxy-glutamic acid residues in the calcium-dependent binding of recombinant human protein C to acidic phospholipid vesicles. J Biol Chem 1993; 268: 12040-12050
    PubMedSearch in Google Scholar
  • 13 Christiansen WT, Geng JP, Castellino FJ. Structure-function assessment of the role of the helical stack domain in the properties of human recombinant protein C and activated protein C. Biochemistry 1995; 34: 8082-8090
    CrossrefPubMedSearch in Google Scholar
  • 14 Stern DM, Nawroth PP, Kisiel W, Vehar G, Esmon CT. The binding of factor IXa to cultured bovine aortic endothelial cells. Induction of a specific site in the presence of factors VIII and X. J Biol Chem 1985; 260: 6717-6722
    PubMedSearch in Google Scholar
  • 15 Rimon S, Melamed R, Savion N, Scott T, Nawroth PP, Stem DM. Identification of a factor IX/IXa binding protein on the endothelial cell surface. J Biol Chem 1987; 262: 6023-6331
    PubMedSearch in Google Scholar
  • 16 Ryan J, Huang LH, Tam JP, Wolitzky B, Heimer E, Lambrose T, Felix A, Nawroth P, Wilner G, Kisiel W, Nelsestuen GL, Stern DM. Structural determinants of the factor IX molecule mediating interaction with the endothelial cell binding site are distinct from those involved in phospholipid binding. J Biol Chem 1989; 264: 20283-20287
    PubMedSearch in Google Scholar
  • 17 Cheung WF, Hamaguchi N, Smith KJ, Stafford DW. The binding of human factor IX to endothelial cells is mediated by residues 3-11. J Biol Chem 1992; 267: 20529-20531
    CrossrefPubMedSearch in Google Scholar
  • 18 Geng J-P, Christiansen WT, Plow EF, Castellino FJ. Transfer of specific endothelial cell-binding properties from the procoagulant protein human factor IX into the anticoagulant protein human protein C. Biochemistry 1995; 34: 8449-8457
    CrossrefPubMedSearch in Google Scholar
  • 19 Fukudome K, Esmon CT. Molecular cloning and expression of murine and bovine endothelial cell protein C/activated protein C receptor (EPCR)–the structural and functional conservation in human, bovine, and murine EPCR. J Biol Chem 1995; 270: 5571-5577
    CrossrefPubMedSearch in Google Scholar
  • 20 Bangalore N, Drohan WN, Orthner CL. Characterization of the interaction between protein C (PC) and activated protein C (APC) with receptors on cultured umbilical vein endothelial cells (HUVEC). Thromb Haemost 1993; 69: 723
    PubMedSearch in Google Scholar
  • 21 Hancock WW, Grey ST, Hau L, Akalin E, Orthner C, Sayegh MH, Salem HH. Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses. Transplantation 1995; 60: 1525-1532
    CrossrefPubMedSearch in Google Scholar
  • 22 Sakai T, Lund-Hansen T, Thim L, Kisiel W. The g-carboxyglutamic acid domain of human factor Vila is essential for its interaction with cell surface tissue factor. J Biol Chem 1990; 265: 1890-1894
    PubMedSearch in Google Scholar
  • 23 Ruf W, Kalnik MW, Lund-Hansen T, Edgington TS. Characterization of factor VII association with tissue factor in solution. High and low affinity calcium binding sites in factor VII contribute to functionally distinct interactions. J Biol Chem 1991; 266: 15719-15725
    PubMedSearch in Google Scholar
  • 24 Toomey JR, Smith KJ, Stafford DW. Localization of the tissue factor recognition determinant of human factor VIIa. J Biol Chem 1991; 266: 19198-19211
    PubMedSearch in Google Scholar
  • 25 Wildgoose P, Jorgensen T, Komiyama Y, Nakagaki T, Pedersen A, Kisiel W. The role of phospholipids and the factor VII gla-domain in the interaction of factor VII with tissue factor. Thromb Haemost 1992; 67: 679-685
    Thieme ConnectPubMedSearch in Google Scholar
  • 26 Chang JY, Stafford DW, Straight DL. The roles of factor VII’s structural domains in tissue factor binding. Biochemistry 1995; 34: 12227-12232
    CrossrefPubMedSearch in Google Scholar
  • 27 Banner DW, D’Arcy A, Chene C, Winkler FK, Guha A, Konigsberg WH, Nemerson Y, Kirchofer D. The crystal structure of the complex of blood coagulation factor VII with soluble tissue factor. Nature 1996; 380: 41-46
    CrossrefPubMedSearch in Google Scholar
  • 28 Zhang L, Castellino FJ. Influence of specific γ-carboxyglutamic acid residues on the integrity of the calcium-dependent conformation of human protein C. J Biol Chem 1992; 267: 26078-26084
    PubMedSearch in Google Scholar
  • 29 Colpitts TL, Castellino FJ. Calcium and phospholipid binding properties of synthetic gamma-carboxyglutamic acid-containing peptides with sequence counterparts in human protein C. Biochemistry 1994; 33: 3501-3508
    CrossrefPubMedSearch in Google Scholar
  • 30 Yu S, Zhang L, Jhingan A, Christiansen WT, Castellino FJ. Construction, expression, and properties of a recombinant human protein C with replacement of its growth factor-like domains by those of human coagulation factor IX. Biochemistry 1994; 33: 823-831
    CrossrefPubMedSearch in Google Scholar
  • 31 Christiansen WT, Castellino FJ. Properties of recombinant chimeric human protein C and activated protein C containing the gamma-carboxyglutamic acid and trailing helical stack domains of protein C replaced by those of human coagulation factor IX. Biochemistry 1994; 33: 5901-5911
    CrossrefPubMedSearch in Google Scholar
  • 32 Zhang L, Castellino FJ. A γ-carboxyglutamic acid variant (γ6D, γ7D) of human activated protein C displays greatly reduced activity as an anticoagulant. Biochemistry 1990; 29: 10828-10834
    CrossrefPubMedSearch in Google Scholar
  • 33 Amphlett GW, Byrne R, Castellino FJ. The binding of metal ions to bovine factor IX. J Biol Chem 1978; 253: 6774-6779
    PubMedSearch in Google Scholar
  • 34 Amphlett GW, Byrne R, Castellino FJ. The binding of calcium to the activation products of bovine factor IX. J Biol Chem 1979; 254: 6333-6336
    PubMedSearch in Google Scholar
  • 35 Meyback B, Heim J, Rink H, Zimmermann W, Maerki W. Desulfato-hirudin, a specific thrombin inhibitor: Expression and secretion in yeast. Thromb Res 1987; 7: 33
    PubMedSearch in Google Scholar
  • 36 Glaser CB, Morser J, Clarke JH, Blasko E, McLean K, Kuhn I, Chang RJ, Lin JH, Vilander L, Andrews WH, Light DR. Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation. J Clin Invest 1992; 90: 2565-2573
    CrossrefPubMedSearch in Google Scholar
  • 37 Fisher KL, Gorman CM, Vehar GA, O’Brien D, Lawn RM. Cloning and expression of human tissue factor cDNA. Thromb Res 1987; 48: 89-99
    CrossrefPubMedSearch in Google Scholar
  • 38 Heeb MJ, Schwartz P, White T, Lammle B, Berrettini M, Griffin J. Immunoblotting studies of the molecular forms of protein C in plasma. Thromb Res 1988; 52: 33-43
    CrossrefPubMedSearch in Google Scholar
  • 39 Wakabayashi K, Sakata Y, Aoki N. Conformation-specific monoclonal antibodies to the calcium-induced structure of protein C. J Biol Chem 1986; 261: 11097-11105
    PubMedSearch in Google Scholar
  • 40 Foster DC, Davie EW. Characterization of a cDNA coding for human protein C. Proc Natl Acad Sci USA 1984; 81: 4766-4770
    CrossrefPubMedSearch in Google Scholar
  • 41 Hagen FS, Gray CL, O’Hara P, Grant FJ, Saari GC, Woodbury RG, Hart CE, Insley M, Kisiel W, Kurachi K, Davie EW. Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci USA 1986; 83: 2412-2416
    CrossrefPubMedSearch in Google Scholar
  • 42 Jhingan A, Zhang L, Christiansen WT, Castellino FJ. The activities of recombinant gamma-carboxyglutamic acid-deficient mutants of activated human protein C toward human coagulation factor VIII and factor Va in purified systems and in plasma. Biochemistry 1994; 33: 1869-1875
    CrossrefPubMedSearch in Google Scholar
  • 43 Clarke BJ, Ofosu FA, Sridhara S, Bona RD, Rickies FR, Blajchman MA. The first epidermal growth factor domain of human coagulation factor VII is essential for binding with tissue factor. FEBS Lett 1992; 298: 206-210
    CrossrefPubMedSearch in Google Scholar
  • 44 Menhart N, Sehl LC, Kelley RF, Castellino FJ. Construction, expression and purification of recombinant kringle 1 of human plasminogen and analysis of its interaction with w-amino acids. Biochemistry 1991; 30: 1948-1957
    CrossrefPubMedSearch in Google Scholar
  • 45 De Serrano VS, Menhart N, Castellino FJ. The expression, purification and characterization of the recombinant kringle 1 domain from tissue-type plasminogen activator. Arch Biochem Biophys 1992; 294: 282-290
    CrossrefPubMedSearch in Google Scholar
  • 46 De Serrano VS, Castellino FJ. The cationic locus on the recombinant kringle 2 domain of tissue-type plasminogen activator that stabilizes its interaction with ω-amino acids (1992). Biochemistry 1992; 31: 11698-11706
    CrossrefPubMedSearch in Google Scholar
  • 47 Chibber BAK, Urano S, Castellino FJ. Synthesis, purification and properties of a peptide that enhances the activation of human [glu1]plasminogen by tissue plasminogen activator and retards fibrin polymerization. Int J Peptide Protein Res 1990; 35: 73-80
    PubMedSearch in Google Scholar
  • 48 Yan SCB, Pazzano P, Chao YB, Walls JD, Berg DT, McClure DB, Grinnell BW. Characterization and novel purification of recombinant human protein C from three mammalian cell lines. Bio/Technology 1990; 8: 655-661
    CrossrefPubMedSearch in Google Scholar
  • 49 Geng J-P, Cheng CH, Castellino FJ. Functional consequences of mutations in amino acid residues that stabilize calcium binding to the first epidermal growth factor homology domain of human protein C. Thromb Haemost 1996; 76: 720-728
    Thieme ConnectPubMedSearch in Google Scholar
  • 50 Geng J-P, Castellino FJ. The propeptides of human protein C, factor VII, and factor IX are exchangeable with regard to directing gamma-carboxyla- tion of these proteins. Thromb Haemost 1996; 76: 205-207
    Thieme ConnectPubMedSearch in Google Scholar
  • 51 Soriano-Garcia M, Padmanabhan K, deVos AM, Tulinsky A. The Ca2+ ion and membrane binding structure of the gla-domain of Ca-prothrombin fragment 1. Biochemistry 1992; 31: 2554-2666
    CrossrefPubMedSearch in Google Scholar
  • 52 Zhang L, Castellino FJ. The binding energy of human coagulation protein C to acidic phospholipid vesicles contains a major contribution from leucine-5 in thegamma-carboxyglutamic acid domain. J Biol Chem 1994; 269: 3590-3595
    PubMedSearch in Google Scholar
  • 53 Christiansen WT, Jalbert LR, Robertson RM, Jhingan A, Prorok M, Castellino FJ. Hydrophobic amino acid residues of human anticoagulation protein C that contribute to its functional binding to phospholipid vesicles. Biochemistry 1995; 34: 10376-10382
    CrossrefPubMedSearch in Google Scholar
  • 54 Jalbert LR, Chan JCY, Christiansen WT, Castellino FJ. The hydrophobic nature of residue-5 of human protein C is a major determinant of its functional interactions with acidic phospholipid vesicles. Biochemistry 1996; 35: 7093-7099
    CrossrefPubMedSearch in Google Scholar
  • 55 Valcarce C, Selander-Sunnerhagen M, Tamlitz AM, Drakenberg T, Bjork I. Stenflo J. Calcium affinity of the NH2-terminal epidermal growth factorlike module of factor X. Effect of the gamma-carboxyglutamic acid-containing module. J Biol Chem 1993; 268: 26673-26678
    PubMedSearch in Google Scholar
  • 56 Esmon NL, DeBault LE, Esmon CT. Proteolytic formation and properties of γ-carboxyglutamic acid-domainless protein C. J Biol Chem 1983; 258: 5548-6553
    PubMedSearch in Google Scholar
  • 57 Lim TK, Bloomfield VA, Nelsestuen GL. Structure of the prothrombin- and blood clotting factor X-membrane complexes. Biochemistry 1977; 16: 4177-4181
    CrossrefPubMedSearch in Google Scholar
  • 58 Isaacs BS, Husten EJ, Esmon CT, Johnson AJ. A domain of membranebound blood coagulation factor Va is located far from the phospholipid surface. A fluorescence energy transfer measurement. Biochemistry 1986; 25: 4958-4969
    CrossrefPubMedSearch in Google Scholar
  • 59 Mutucumarana VP, Duffy EJ, Lollar P, Johnson AE. The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor Villa. J Biol Chem 1992; 267: 17012-17021
    CrossrefPubMedSearch in Google Scholar
  • 60 Zhang L, Jhingan A, Castellino FJ. Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity. Blood 1992; 80: 942-952
    PubMedSearch in Google Scholar